Citigroup’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Citigroup's CLB Position: Q2 2026 in Review
Citigroup increased its Core Laboratories (CLB) stake by 163% in Q2 2026, buying an estimated $651K and bringing the position to 73,484 shares worth $856K. The position accounts for ﹤0.01% of the portfolio, ranked #3562.
Citigroup first reported a position in CLB in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.9M in Q2 2018. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Citigroup held 73,484 shares of Core Laboratories worth $856K as of Q2 2026.
- Citigroup bought 45,579 Core Laboratories shares in Q2 2026, an estimated $651K.
- Core Laboratories made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3562 holding.
- Citigroup first reported a position in Core Laboratories in Q2 2013 and has held it in 53 quarters since.
- Citigroup's Core Laboratories position peaked at $15.9M in Q2 2018.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.